Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
- DOI
- 10.1111/dom.14296
- Published
- 2021 Apr
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.14296,
title = {Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.},
author = {Kosiborod M and Berwanger O and Koch GG and Martinez F and Mukhtar O and Verma S and Chopra V and Javaheri A and Ambery P and Gasparyan SB and Buenconsejo J and Sjöström CD and Langkilde AM and Oscarsson J and Esterline R},
year = {2021},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.14296},
url = {https://doi.org/10.1111/dom.14296}
}RIS
TY - JOUR TI - Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. AU - Kosiborod M AU - Berwanger O AU - Koch GG AU - Martinez F AU - Mukhtar O AU - Verma S AU - Chopra V AU - Javaheri A AU - Ambery P AU - Gasparyan SB AU - Buenconsejo J AU - Sjöström CD AU - Langkilde AM AU - Oscarsson J AU - Esterline R PY - 2021 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.14296 UR - https://doi.org/10.1111/dom.14296 ER -
APA
M, K., O, B., GG, K., F, M., O, M., S, V., V, C., A, J., P, A., SB, G., J, B., CD, S., AM, L., J, O., & R, E. (2021). Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.14296
Source records
- pubmed · retrieved 2026-09-26T16:04:31.643Z